Clinical update – A focus on direct oral anticoagulants (DOACs)
Recent real-world evidence of the benefits of direct oral anticoagulants (DOACs) provides practical guidance on protecting vulnerable, high-risk patients from stroke and VTE
Learning objectives
You will learn:
- An understanding of the real-world and clinical trial evidence underpinning recent changes to guidelines on the management of atrial fibrillation (AF), with a focus on patient-centred care
- Reasons for increasing prevalence of AF
- Revised diagnostic criteria and symptoms attributable to AF
- Familiarity with recently revised and simplified stroke and thromboembolism risk calculations
- The role of direct oral anticoagulation in protection against stroke and venous thromboembolism, and the real-world safety profile of DOACs
- Assessment and management of bleeding risk.
To access this module, please register or login: